Li Bai

1.9k total citations
74 papers, 1.1k citations indexed

About

Li Bai is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Li Bai has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 27 papers in Oncology and 21 papers in Hepatology. Recurrent topics in Li Bai's work include Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Li Bai is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Li Bai collaborates with scholars based in China, United Kingdom and United States. Li Bai's co-authors include Sujun Zheng, Zhongping Duan, Zhiyuan Mao, Xiaohui Zhang, Shunchang Jiao, Guifang Wang, Chunxue Bai, Chunling Dong, Cha‐Xiang Guan and Kui Xiao and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.

In The Last Decade

Li Bai

71 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li Bai China	19	359	288	281	237	181	74	1.1k
Peter Dietrich Germany	21	387 1.1×	543 1.9×	172 0.6×	190 0.8×	197 1.1×	50	1.3k
Kazunori Kawaguchi Japan	20	330 0.9×	196 0.7×	239 0.9×	371 1.6×	147 0.8×	68	1.1k
Feixiang Wu China	24	359 1.0×	551 1.9×	290 1.0×	494 2.1×	246 1.4×	48	1.5k
Nga Nguyen United States	22	270 0.8×	384 1.3×	189 0.7×	184 0.8×	82 0.5×	47	1.4k
Yunfeng Shan China	20	168 0.5×	627 2.2×	311 1.1×	191 0.8×	233 1.3×	67	1.2k
Rui Zhu China	22	181 0.5×	484 1.7×	150 0.5×	85 0.4×	143 0.8×	63	1.2k
Përparim Limani Switzerland	18	247 0.7×	204 0.7×	158 0.6×	292 1.2×	370 2.0×	41	893
Anna Moles Spain	20	477 1.3×	486 1.7×	115 0.4×	338 1.4×	166 0.9×	29	1.3k
Songbai Lin United States	16	785 2.2×	777 2.7×	268 1.0×	176 0.7×	395 2.2×	20	1.9k

Countries citing papers authored by Li Bai

Since Specialization

Citations

This map shows the geographic impact of Li Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Bai more than expected).

Fields of papers citing papers by Li Bai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Bai. The network helps show where Li Bai may publish in the future.

Co-authorship network of co-authors of Li Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Li Bai. A scholar is included among the top collaborators of Li Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Bai. Li Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Desai, Jayesh, Sophia Frentzas, Marwan Fakih, et al.. (2025). First-in-human, phase 1a, dose escalation study of BGB-B167, a CEA x 4-1BB bispecific antibody, as monotherapy or combined with tislelizumab (anti-PD-1), in patients with selected advanced or metastatic solid tumors.. Journal of Clinical Oncology. 43(4_suppl). 123–123.

Bai, Li, et al.. (2025). Molecularly imprinted polymer coated Eu-BCA MOF for highly selective detection of Zearalenone in corn oil. Food Chemistry. 489. 144872–144872. 6 indexed citations

Xu, Wei, et al.. (2024). Knowledge and Practices Regarding Human Papillomavirus and Cervical Cancer Screening Among Women in Low-Income Areas of China: A Cross-Sectional Study. Cureus. 16(3). e55930–e55930.

Huang, Jinghui, Jiamin Li, Ying Li, et al.. (2024). Bibliometric analysis of breast cancer-related lymphedema research trends over the last 2 decades. Frontiers in Oncology. 14. 1360899–1360899. 2 indexed citations

Xu, Wei, Siyuan Yang, Dehua Hu, et al.. (2024). Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China. Cureus. 16(4). e58081–e58081. 2 indexed citations

Ye, Sisi, Li Bai, Yujuan Qi, et al.. (2023). Retrospective analysis of colorectal cancer patients with metachronous initially unresectable liver metastases (and no other) achieving no evidence of disease after first-line comprehensive therapy: a multicenter real-world study. Journal of Cancer Research and Clinical Oncology. 149(11). 8403–8413. 2 indexed citations

Huang, Qing, Ran An, Haixuan Wang, et al.. (2023). Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice. Emerging Microbes & Infections. 12(1). 2203782–2203782. 11 indexed citations

Wang, Changcong, et al.. (2023). A study of factors impacting disease based on the Charlson Comorbidity Index in UK Biobank. Frontiers in Public Health. 10. 1050129–1050129. 4 indexed citations

Qiao, Qian, Chun Han, Sisi Ye, et al.. (2023). The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial. Frontiers in Immunology. 14. 1238667–1238667. 30 indexed citations

10.

Wang, Yang, Hao Liao, Yanna Liu, et al.. (2022). Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues. Journal of Viral Hepatitis. 29(6). 420–431. 11 indexed citations

11.

Yuan, Boyu, Mingming Liu, Zifan Wang, et al.. (2022). Sodium butyrate exerts antioxidant stress effects and attenuates Aβ25-35-induced cytotoxicity in PC12 cells. Archives of Biochemistry and Biophysics. 731. 109448–109448. 8 indexed citations

12.

Ren, Yan, Jing Zhao, Manman Xu, et al.. (2022). Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B. International Journal of Medical Sciences. 19(14). 2080–2086. 2 indexed citations

13.

Li, Lu, Hui Liu, Shuang Liu, et al.. (2021). UGT1A1-related Bilirubin Encephalopathy/Kernicterus in Adults. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations

14.

Ding, Yan-qing, Yuhong Zhang, Jing Lü, et al.. (2020). MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction. Acta Pharmacologica Sinica. 42(9). 1422–1436. 35 indexed citations

15.

Bai, Li, et al.. (2020). <p>Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma</p>. Cancer Management and Research. Volume 12. 2839–2851. 10 indexed citations

16.

Lopez, Maria Yanez, Marie‐Christine Pardon, Kerstin Baiker, et al.. (2019). Myoinositol CEST signal in animals with increased Iba-1 levels in response to an inflammatory challenge—Preliminary findings. PLoS ONE. 14(2). e0212002–e0212002. 9 indexed citations

17.

Wang, Lijie, Dan Su, Tingting Zhang, et al.. (2015). Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: a meta analysis.. PubMed Central. 8(1). 650–7. 8 indexed citations

18.

Zhang, Tingting, Dan Su, Juan Li, et al.. (2015). [Clinical efficacy observation of cetuximab combined with chemotherapy in the treatment of metastatic colorectal carcinoma].. PubMed. 18(6). 584–8. 1 indexed citations

19.

Wang, Lijie, Li Bai, Dan Su, Ting Zhang, & Zhiyuan Mao. (2013). Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathways. Molecular and Cellular Biochemistry. 381(1-2). 173–181. 6 indexed citations

20.

Bai, Li, et al.. (1999). Evaluation on factors influencing liver cancer metastasis after liver surgery by a mouse model. Chinese Journal of Cancer Research. 11(2). 101–104. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact